UK
Udaya Kiran Perla
About Udaya Kiran Perla
Data last updated:
Udaya Kiran Perla is a Managing Director at Starus Pharmaceuticals Private Limited (since 2016), Director at Starus Pharmaceuticals Industries Private Limited (since 2019) and Managing Director at Unicon Pharma Private Limited (since 2020), and holds 4 more current directorships. The companies operate in Pharma, Chemicals and Materials and Chemicals. The 5 current companies with reported revenue have a combined latest revenue of ₹36.87 Cr; the largest is Starus Pharmaceuticals Private Limited at ₹15.05 Cr (FY 2022). Earlier, Udaya Kiran Perla was a Director at Sarath Meditech Private Limited (2022–2025) and Director at Spectrogen Pharmachem Limited (2020–2022) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Starus Pharmaceuticals Private Limited U24304TG2016PTC113632 | Managing Director | 22 Dec 2016 | 2016 | ₹15.05 Cr (FY 2022) | Active |
| Starus Pharmaceuticals Industries Private Limited U24230TG2019PTC136770 | Director | 14 Nov 2019 | 2019 | ₹13.72 Cr (FY 2023) | Active |
 Unicon Pharma Private Limited U24100TG2020PTC143959 | Managing Director | 16 Sep 2020 | 2020 | ₹3.58 Cr (FY 2024) | Active |
| Spanus Pharmaceuticals Private Limited U24239TG2019PTC130023 | Managing Director | 25 Jan 2019 | 2019 | ₹2.83 Cr (FY 2022) | Active |
| Layerly Pharmaceuticals Private Limited U24110TG2019PTC133555 | Managing Director | 20 Jun 2019 | 2019 | ₹1.68 Cr (FY 2022) | Active |
| Starixo Medisolutions Private Limited U46497TS2026PTC209232 | Director | 06 Jan 2026 | 2026 | Active | |
| Unistar Pharma Private Limited U21009TS2023PTC171397 | Director | 27 Mar 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Sarath Meditech Private Limited U24100TG2022PTC166614 | Director | 13 Sep 2022 | 2022 | Active | |
 Spectrogen Pharmachem Limited U24299TG2020PLC147109 | Director | 22 Dec 2020 | 2020 | ₹8.21 Cr (FY 2023) | Active |
| Sangeetha Holidays Private Limited U63030TG2021PTC148342 | Director | 05 Feb 2021 | 2021 | ₹7.7 Lakh (FY 2025) | Active |
| Wellshark Pharmaceuticals Private Limited U24299TG2019PTC136767 | Director | 14 Nov 2019 | 2019 | ₹62.8 Lakh (FY 2024) | Active |
 Helse Pharmaceuticals Private Limited U33111TG2015PTC101467 | Director | 03 Nov 2015 | 2015 | ₹64.1 Lakh (FY 2020) | Active |
| Sunaxa Pharma Llp AAJ-5222 | Designated Partner | 02 Aug 2018 | 2017 | Converted And Dissolved |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Udaya Kiran Perla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ramesh Kumar Modukuri | 07768787 | Starus Pharmaceuticals Private Limited , Starus Pharmaceuticals Industries Private Limited and 1 more | Director |
| Ravi Kumar Kollipora | 00758622 | Unicon Pharma Private Limited , Unistar Pharma Private Limited | Director |
| Rama Subrahmanyam Sana | 08342223 | Spanus Pharmaceuticals Private Limited | Director |
| Sri Chandana Modukuri | 07689464 | Spanus Pharmaceuticals Private Limited | Director |
| Srinivasa Babu Yadala | 08488893 | Layerly Pharmaceuticals Private Limited | Director |
| Raghavender Reddy Challa | 11466430 | Starixo Medisolutions Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Udaya Kiran Perla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Udaya Kiran Perla
Udaya Kiran Perla currently holds 7 directorships: Starus Pharmaceuticals Private Limited (Managing Director, since 22 Dec 2016, revenue ₹15.05 Cr (FY 2022)); Starus Pharmaceuticals Industries Private Limited (Director, since 14 Nov 2019, revenue ₹13.72 Cr (FY 2023)); Unicon Pharma Private Limited (Managing Director, since 16 Sep 2020, revenue ₹3.58 Cr (FY 2024)); Spanus Pharmaceuticals Private Limited (Managing Director, since 25 Jan 2019, revenue ₹2.83 Cr (FY 2022)); Layerly Pharmaceuticals Private Limited (Managing Director, since 20 Jun 2019, revenue ₹1.68 Cr (FY 2022)); and 2 more.
Udaya Kiran Perla was first appointed on 03 Nov 2015 as Director at Helse Pharmaceuticals Private Limited. The most recent appointment on record is 06 Jan 2026 at Starixo Medisolutions Private Limited.
The 5 current companies of Udaya Kiran Perla that report revenue have a combined latest revenue of ₹36.87 Cr: Starus Pharmaceuticals Private Limited ₹15.05 Cr (FY 2022); Starus Pharmaceuticals Industries Private Limited ₹13.72 Cr (FY 2023); Unicon Pharma Private Limited ₹3.58 Cr (FY 2024); Spanus Pharmaceuticals Private Limited ₹2.83 Cr (FY 2022); Layerly Pharmaceuticals Private Limited ₹1.68 Cr (FY 2022).
Udaya Kiran Perla held 6 earlier board appointments: Sarath Meditech Private Limited (Director, 13 Sep 2022 to 31 May 2025); Spectrogen Pharmachem Limited (Director, 22 Dec 2020 to 22 Aug 2022); Sangeetha Holidays Private Limited (Director, 05 Feb 2021 to 03 Mar 2022); Wellshark Pharmaceuticals Private Limited (Director, 14 Nov 2019 to 13 Nov 2021); Helse Pharmaceuticals Private Limited (Director, 03 Nov 2015 to 23 Oct 2017); and 1 more.
The current boards of Udaya Kiran Perla's companies include Ramesh Kumar Modukuri (Starus Pharmaceuticals Private Limited), Ravi Kumar Kollipora (Unicon Pharma Private Limited), Rama Subrahmanyam Sana (Spanus Pharmaceuticals Private Limited), Sri Chandana Modukuri (Spanus Pharmaceuticals Private Limited), Srinivasa Babu Yadala (Layerly Pharmaceuticals Private Limited), Raghavender Reddy Challa (Starixo Medisolutions Private Limited).